2024-07-17
Reuters
6 related
Israel-based CytoReason, which uses AI to develop disease models, raised $80M from Nvidia, Pfizer, Thermo Fisher, and OurCrowd, and plans a Massachusetts office
Israel's CytoReason, which uses AI to develop disease models, said on Wednesday it had raised $80 million in a private funding round.
2024-03-06
Globes Online
4 related
Industrial cybersecurity startup Claroty raised $100M in a “pre-IPO round” at an estimated $2.5B valuation and reports $100M ARR, after raising $400M in 2021
Claroty provides infrastructure cybersecurity and secures connected devices in all Pfizer, BMW, Siemens and Schneider plants.
2023-01-25
TechCrunch
7 related
UK-based enterprise VR training startup Gemba, used by Coca-Cola, Pfizer, and more, raised an $18M Series A led by Parkway; courses can cost ~$7,250 per person
Paul Sawers / TechCrunch :
Loading articles...